Tamara Pringsheim1, Mark Edwards1. 1. Department of Clinical Neurosciences, Psychiatry, Pediatrics, and Community Health Sciences (TP), University of Calgary, Canada; and St George's University of London (ME), UK.
Abstract
PURPOSE OF REVIEW: Functional movement disorders (FMD) are commonly seen in neurologic practice, but are associated with poor outcomes. Recent years have seen a resurgence of interest in this area, with new developments in pathophysiologic understanding and therapeutic management. RECENT FINDINGS: Individuals with FMD are a psychologically heterogeneous group, with many individuals having no detectable psychopathology on symptom screening measures, and possibly significant etiologically relevant life events only revealed through in-depth interviews. A randomized trial of specialist intensive physical rehabilitation compared to community-based neurophysiotherapy in FMD has demonstrated moderate to large effect sizes for both physical and social functioning outcomes. Experimental evidence suggests an impairment in the neural systems conferring a sense of agency over movement in individuals with FMD, and may explain why movements that appear voluntary are not experienced as such. SUMMARY: The prognosis of individuals with FMD may be improved with greater access to appropriately organized care and treatment.
PURPOSE OF REVIEW: Functional movement disorders (FMD) are commonly seen in neurologic practice, but are associated with poor outcomes. Recent years have seen a resurgence of interest in this area, with new developments in pathophysiologic understanding and therapeutic management. RECENT FINDINGS: Individuals with FMD are a psychologically heterogeneous group, with many individuals having no detectable psychopathology on symptom screening measures, and possibly significant etiologically relevant life events only revealed through in-depth interviews. A randomized trial of specialist intensive physical rehabilitation compared to community-based neurophysiotherapy in FMD has demonstrated moderate to large effect sizes for both physical and social functioning outcomes. Experimental evidence suggests an impairment in the neural systems conferring a sense of agency over movement in individuals with FMD, and may explain why movements that appear voluntary are not experienced as such. SUMMARY: The prognosis of individuals with FMD may be improved with greater access to appropriately organized care and treatment.
Authors: J Stone; A Carson; R Duncan; R Roberts; C Warlow; C Hibberd; R Coleman; R Cull; G Murray; A Pelosi; J Cavanagh; K Matthews; R Goldbeck; R Smyth; J Walker; M Sharpe Journal: Clin Neurol Neurosurg Date: 2010-06-19 Impact factor: 1.876
Authors: Renske M van der Hoeven; Marja Broersma; Gerdina H M Pijnenborg; Elouise A Koops; Teus van Laar; Jon Stone; Marije van Beilen Journal: J Psychosom Res Date: 2015-06-14 Impact factor: 3.006
Authors: Selma Aybek; Timothy R Nicholson; Fernando Zelaya; Owen G O'Daly; Tom J Craig; Anthony S David; Richard A Kanaan Journal: JAMA Psychiatry Date: 2014-01 Impact factor: 21.596
Authors: Glenn Nielsen; Jon Stone; Audrey Matthews; Melanie Brown; Chris Sparkes; Ross Farmer; Lindsay Masterton; Linsey Duncan; Alisa Winters; Laura Daniell; Carrie Lumsden; Alan Carson; Anthony S David; Mark Edwards Journal: J Neurol Neurosurg Psychiatry Date: 2014-11-28 Impact factor: 10.154